{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:23:46Z","timestamp":1792113826906,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Nanotechnology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Science","award":["N-0104"],"award-info":[{"award-number":["N-0104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13346-024-01663-1","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T11:02:05Z","timestamp":1720436525000},"page":"1210-1220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chitosan\/carbomer nanoparticles- laden in situ gel for improved ocular delivery of timolol: in vitro, in vivo, and ex vivo study"],"prefix":"10.1007","volume":"15","author":[{"given":"Nadereh","family":"Rahbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Darvish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereydoun","family":"Farrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-7335","authenticated-orcid":false,"given":"Maryam","family":"Kouchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"issue":"3","key":"1663_CR1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1185\/03007990903498786","volume":"26","author":"M Orme","year":"2010","unstructured":"Orme M, et al. Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension. Curr Med Res Opin. 2010;26(3):511\u201328.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1663_CR2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.17116\/oftalma201913502132","volume":"135","author":"AL Onishchenko","year":"2019","unstructured":"Onishchenko AL, et al. Initial combination therapy for primary open-angle glaucoma. Vestn Oftalmol. 2019;135(2):32\u20138.","journal-title":"Vestn Oftalmol"},{"issue":"10","key":"1663_CR3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00417-010-1383-0","volume":"248","author":"IP Kaur","year":"2010","unstructured":"Kaur IP, et al. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1467\u201372.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1663_CR4","doi-asserted-by":"crossref","first-page":"105553","DOI":"10.1016\/j.ejps.2020.105553","volume":"155","author":"A Fayyaz","year":"2020","unstructured":"Fayyaz A, et al. Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits. Eur J Pharm Sci. 2020;155:105553.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"1663_CR5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s13346-022-01266-8","volume":"13","author":"A Bigdeli","year":"2023","unstructured":"Bigdeli A, et al. Cationic liposomes as promising vehicles for timolol\/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro\/in vivo evaluation. Drug Deliv Transl Res. 2023;13(4):1035\u201347.","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"1663_CR6","first-page":"322","volume":"10","author":"Y Zubairu","year":"2015","unstructured":"Zubairu Y, et al. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations. Asian J Pharm Sci. 2015;10(4):322\u201330.","journal-title":"Asian J Pharm Sci"},{"key":"1663_CR7","first-page":"387","volume":"4","author":"K Manish","year":"2012","unstructured":"Manish K, Kulkarni G. Recent advances in ophthalmic drug delivery system. Int J Pharm Pharm Sci. 2012;4:387.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1663_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01589-8","author":"F Paleel","year":"2024","unstructured":"Paleel F, et al. Manufacturing and characterisation of 3D-printed sustained-release Timolol implants for glaucoma treatment. Drug Deliv Transl Res. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01589-8","journal-title":"Drug Deliv Transl Res"},{"key":"1663_CR9","doi-asserted-by":"crossref","first-page":"123021","DOI":"10.1016\/j.ijpharm.2023.123021","volume":"640","author":"B Uner","year":"2023","unstructured":"Uner B, et al. Timolol-loaded ethosomes for ophthalmic delivery: reduction of high intraocular pressure in vivo. Int J Pharm. 2023;640:123021.","journal-title":"Int J Pharm"},{"issue":"1","key":"1663_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2012.04.060","volume":"432","author":"R Bhatta","year":"2012","unstructured":"Bhatta R, et al. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharm. 2012;432(1):105\u201312.","journal-title":"Int J Pharm"},{"key":"1663_CR11","doi-asserted-by":"crossref","first-page":"101736","DOI":"10.1016\/j.jddst.2020.101736","volume":"57","author":"U Shivam","year":"2020","unstructured":"Shivam U. Nanoparticles laden in situ gel for sustained drug release after topical ocular administration. J Drug Deliv Sci Technol. 2020;57:101736.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1663_CR12","doi-asserted-by":"crossref","unstructured":"Albarqi HA et al. Recent progress in chitosan-based nanomedicine for its ocular application in glaucoma. Pharmaceutics. 2023;15(2).","DOI":"10.3390\/pharmaceutics15020681"},{"issue":"6","key":"1663_CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4274\/tjps.galenos.2021.40121","volume":"19","author":"WN Sheshala","year":"2021","unstructured":"Sheshala WN, Said R, Ashraf ID, Lim K, Ramasamy SM, Zeeshan K. Poloxamer and Chitosan-based in situ gels loaded with Orthosiphon Stamineus Benth. Extracts containing rosmarinic acid for the treatment of ocular infections. Turk J Pharm Sci. 2021;19(6):671\u201380.","journal-title":"Turk J Pharm Sci"},{"key":"1663_CR14","doi-asserted-by":"crossref","first-page":"116126","DOI":"10.1016\/j.carbpol.2020.116126","volume":"238","author":"D Wu","year":"2020","unstructured":"Wu D, et al. Chitosan-based Colloidal Polyelectrolyte complexes for Drug Delivery: a review. Carbohydr Polym. 2020;238:116126.","journal-title":"Carbohydr Polym"},{"issue":"9","key":"1663_CR15","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1023\/A:1018967116988","volume":"11","author":"P Artursson","year":"1994","unstructured":"Artursson P, et al. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res. 1994;11(9):1358\u201361.","journal-title":"Pharm Res"},{"key":"1663_CR16","first-page":"420","volume":"2","author":"S Selvaraj","year":"2010","unstructured":"Selvaraj S, et al. Acyclovir loaded chitosan nanoparticles for ocular delivery. Der Pharmacia Lettre. 2010;2:420\u201331.","journal-title":"Der Pharmacia Lettre"},{"key":"1663_CR17","doi-asserted-by":"crossref","first-page":"104849","DOI":"10.1016\/j.reactfunctpolym.2021.104849","volume":"161","author":"M Yanat","year":"2021","unstructured":"Yanat M, Schro\u00ebn K. Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging. React Funct Polym. 2021;161:104849.","journal-title":"React Funct Polym"},{"key":"1663_CR18","unstructured":"Patil J et al. Ionotropic gelation and polyelectrolyte complexation: the novel techniques to design hydrogel particulate sustained, modulated drug delivery system: a review. Dig J Nanomater Biostruct. 2010; 5."},{"issue":"2","key":"1663_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1211\/jpp.58.2.0004","volume":"58","author":"HJ Kao","year":"2006","unstructured":"Kao HJ, et al. Characterization of pilocarpine-loaded chitosan\/carbopol nanoparticles. J Pharm Pharmacol. 2006;58(2):179\u201386.","journal-title":"J Pharm Pharmacol"},{"issue":"7","key":"1663_CR20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1023\/B:PHAM.0000033006.11619.07","volume":"21","author":"MT Islam","year":"2004","unstructured":"Islam MT, et al. Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res. 2004;21(7):1192\u201399.","journal-title":"Pharm Res"},{"key":"1663_CR21","doi-asserted-by":"crossref","unstructured":"Aguilar-L\u00f3pez YA, Villafuerte-Robles L. Functional performance of chitosan\/carbopol 974P NF matrices in captopril tablets. J Pharm (Cairo). 2016;2016:3240290.","DOI":"10.1155\/2016\/3240290"},{"issue":"5","key":"1663_CR22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/B:PHAM.0000026432.75781.cb","volume":"21","author":"AM De Campos","year":"2004","unstructured":"De Campos AM, et al. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res. 2004;21(5):803\u201310.","journal-title":"Pharm Res"},{"issue":"5","key":"1663_CR23","first-page":"60","volume":"3","author":"H Dol","year":"2014","unstructured":"Dol H, et al. Formulation and evaluation of in situ ophthalmic gel of moxifloxacin hydrochloride. Pharma Innov. 2014;3(5):60\u20136.","journal-title":"Pharma Innov"},{"issue":"2","key":"1663_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein MH, et al. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36(2):361\u20138.","journal-title":"Eye (Lond)"},{"issue":"1","key":"1663_CR25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1248\/yakushi.127.183","volume":"127","author":"C Wu","year":"2007","unstructured":"Wu C, et al. Preparation and evaluation of a Carbopol\/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi. 2007;127(1):183\u201391.","journal-title":"Yakugaku Zasshi"},{"issue":"2","key":"1663_CR26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/0975-7406.111824","volume":"5","author":"H Gupta","year":"2013","unstructured":"Gupta H, et al. Nanoparticles laden in situ gel for sustained ocular drug delivery. J Pharm Bioallied Sci. 2013;5(2):162.","journal-title":"J Pharm Bioallied Sci"},{"issue":"4","key":"1663_CR27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3797\/scipharm.1001-06","volume":"78","author":"S Gupta","year":"2010","unstructured":"Gupta S, Vyas SP. Carbopol\/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci Pharm. 2010;78(4):959.","journal-title":"Sci Pharm"},{"issue":"5","key":"1663_CR28","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/03639045.2012.707203","volume":"39","author":"MK Pathak","year":"2013","unstructured":"Pathak MK, Chhabra G, Pathak K. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm. 2013;39(5):780\u201390.","journal-title":"Drug Dev Ind Pharm"},{"key":"1663_CR29","doi-asserted-by":"crossref","unstructured":"Moghimipour E et al. The effect of polymer content on the non-newtonian behavior of acetaminophen suspension. J drug deliv. 2013; 2013.","DOI":"10.1155\/2013\/907471"},{"issue":"4","key":"1663_CR30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejps.2007.08.006","volume":"32","author":"NM Zaki","year":"2007","unstructured":"Zaki NM, et al. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci. 2007;32(4):296\u2013307.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1663_CR31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.colsurfa.2005.02.020","volume":"259","author":"LM Zhang","year":"2005","unstructured":"Zhang LM, Zhou JF, Hui PS. Thickening, shear thinning and thixotropic behavior of a new polysaccharide-based polyampholyte in aqueous solutions. Colloids Surf a: Physicochem. 2005;259(1):189\u201395.","journal-title":"Colloids Surf a: Physicochem"},{"issue":"1","key":"1663_CR32","first-page":"205","volume":"15","author":"M Kouchak","year":"2016","unstructured":"Kouchak M, Bahmandar R, Bavarsad N. Ocular dorzolamide nanoliposomes for prolonged IOP reduction: in-vitro and in-vivo evaluation in rabbits. Iran J Pharm Res. 2016;15(1):205\u201312.","journal-title":"Iran J Pharm Res"},{"key":"1663_CR33","first-page":"3715","volume":"8","author":"W Zhou","year":"2013","unstructured":"Zhou W, et al. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B. Int J Nanomed. 2013;8:3715\u201328.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1663_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(98)00027-1","volume":"166","author":"P He","year":"1998","unstructured":"He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998;166(1):75\u201388.","journal-title":"Int J Pharm"},{"key":"1663_CR35","doi-asserted-by":"crossref","first-page":"114326","DOI":"10.1016\/j.ejpb.2024.114326","volume":"200","author":"MJ Ramalho","year":"2024","unstructured":"Ramalho MJ, et al. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy. Eur J Pharm Biopharm. 2024;200:114326.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1663_CR36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4274\/tjps.54265","volume":"15","author":"S Ren\u00e7ber","year":"2018","unstructured":"Ren\u00e7ber S, Karavana SY. Development and in vitro evaluation of Voriconazole Nanoparticle Formulation for Mucosal Application. Turk J Pharm Sci. 2018;15(2):142\u201348.","journal-title":"Turk J Pharm Sci"},{"key":"1663_CR37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2017.01.013","volume":"100","author":"C Yousry","year":"2017","unstructured":"Yousry C, et al. Studying the influence of formulation and process variables on vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery. Eur J Pharm Sci. 2017;100:142\u201354.","journal-title":"Eur J Pharm Sci"},{"key":"1663_CR38","doi-asserted-by":"crossref","first-page":"118734","DOI":"10.1016\/j.ijpharm.2019.118734","volume":"574","author":"PL Destruel","year":"2020","unstructured":"Destruel PL, et al. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time. Int J Pharm. 2020;574:118734.","journal-title":"Int J Pharm"},{"key":"1663_CR39","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska A et al. Nanopharmaceuticals for Eye Administration: sterilization, depyrogenation and clinical applications. Biology (Basel). 2020; 9(10).","DOI":"10.3390\/biology9100336"},{"issue":"3","key":"1663_CR40","first-page":"942","volume":"6","author":"A Dubey","year":"2014","unstructured":"Dubey A, Prabhu P. Development and investigation of niosomes of Brimonidine tartrate and Timolol maleate for the treatment of glaucoma. Development. 2014;6(3):942\u201350.","journal-title":"Development"},{"issue":"1","key":"1663_CR41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","volume":"290","author":"D Aggarwal","year":"2005","unstructured":"Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm. 2005;290(1):155\u20139.","journal-title":"Int J Pharm"},{"key":"1663_CR42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.exer.2014.02.004","volume":"121","author":"H Zhang","year":"2014","unstructured":"Zhang H, et al. Validation of rebound tonometry for intraocular pressure measurement in the rabbit. Exp Eye Res. 2014;121:86\u201393.","journal-title":"Exp Eye Res"},{"issue":"1\u20132","key":"1663_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","volume":"111","author":"RG Alany","year":"2006","unstructured":"Alany RG, et al. W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. J Control Release. 2006;111(1\u20132):145\u201352.","journal-title":"J Control Release"},{"issue":"42","key":"1663_CR44","doi-asserted-by":"crossref","first-page":"425101","DOI":"10.1088\/1361-6528\/aad7da","volume":"29","author":"Y Wen","year":"2018","unstructured":"Wen Y, et al. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone. Nanotechnology. 2018;29(42):425101.","journal-title":"Nanotechnology"},{"issue":"1","key":"1663_CR45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2014.10.035","volume":"477","author":"H Chandasana","year":"2014","unstructured":"Chandasana H, et al. Corneal targeted nanoparticles for sustained natamycin delivery and their PK\/PD indices: an approach to reduce dose and dosing frequency. Int J Pharm. 2014;477(1):317\u201325.","journal-title":"Int J Pharm"},{"issue":"1","key":"1663_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25\u201335.","journal-title":"Int J Pharm"},{"issue":"3","key":"1663_CR47","doi-asserted-by":"crossref","first-page":"e0264825","DOI":"10.1371\/journal.pone.0264825","volume":"17","author":"NS Heredia","year":"2022","unstructured":"Heredia NS, et al. Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid). PLoS ONE. 2022;17(3):e0264825.","journal-title":"PLoS ONE"},{"key":"1663_CR48","doi-asserted-by":"crossref","unstructured":"Attama AA et al. Chapter 6 - Applications of nanoemulsions as drug delivery vehicle for phytoconstituents, in Nanotechnology in Herbal Medicine, S. Thomas, Editors. 2023, Woodhead Publishing. pp. 119\u2013\u200994.","DOI":"10.1016\/B978-0-323-99527-6.00017-3"},{"key":"1663_CR49","doi-asserted-by":"crossref","first-page":"102397","DOI":"10.1016\/j.sbi.2022.102397","volume":"75","author":"OM Sokolovskaya","year":"2022","unstructured":"Sokolovskaya OM, Tan MW, Wolan DW. Sialic acid diversity in the human gut: molecular impacts and tools for future discovery. Curr Opin Struct Biol. 2022;75:102397.","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"1663_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0975-7406.76478","volume":"3","author":"R Shaikh","year":"2011","unstructured":"Shaikh R, et al. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89.","journal-title":"J Pharm Bioallied Sci"},{"key":"1663_CR51","doi-asserted-by":"crossref","unstructured":"Irimia T et al. Chitosan-based in situ gels for ocular delivery of therapeutics: a state-of-the-art review. Mar Drugs. 2018; 16(10).","DOI":"10.3390\/md16100373"},{"key":"1663_CR52","doi-asserted-by":"crossref","unstructured":"Guerini M, Condr\u00f2 G, Perugini P. Evaluation of the mucoadhesive properties of chitosan-based microstructured lipid carrier (CH-MLC). Pharmaceutics. 2022; 14(1).","DOI":"10.3390\/pharmaceutics14010170"},{"issue":"4","key":"1663_CR53","first-page":"251","volume":"53","author":"J Balasubramaniam","year":"2003","unstructured":"Balasubramaniam J, Kant S, Pandit JK. In vitro and in vivo evaluation of Gelrite\u00ae Gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 2003;53(4):251\u201362.","journal-title":"Acta Pharm"},{"issue":"1","key":"1663_CR54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/fluids4010003","volume":"4","author":"R Varges","year":"2019","unstructured":"Varges R. Rheological Characterization of Carbopol\u00ae Dispersions in Water and in Water\/Glycerol Solutions. Fluids. 2019;4(1):3.","journal-title":"Fluids"},{"key":"1663_CR55","doi-asserted-by":"crossref","unstructured":"Baranowski P et al. Ophthalmic drug dosage forms: characterisation and research methods. The Scientific World Journal. 2014;2014.","DOI":"10.1155\/2014\/861904"},{"issue":"1","key":"1663_CR56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3844\/ajidsp.2012.41.49","volume":"8","author":"D Anjana","year":"2012","unstructured":"Anjana D, et al. Development of curcumin based ophthalmic formulation. Am J Infect Dis. 2012;8(1):41.","journal-title":"Am J Infect Dis"},{"issue":"12","key":"1663_CR57","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1167\/iovs.14-14700","volume":"55","author":"M Vicario-de-la-Torre","year":"2014","unstructured":"Vicario-de-la-Torre M, et al. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film. Invest Phthalmol Vis Sci. 2014;55(12):7839\u201347.","journal-title":"Invest Phthalmol Vis Sci"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01663-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:14:08Z","timestamp":1740748448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01663-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01663-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"29 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was designed and conducted with the permission of the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences (2 July 2022\/IR.AJUMS. REC.1401.126).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors are satisfied with this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of financial or non-financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experiments comply with the current laws of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}